Cited by 169Protease and Inhibitor MechanismsMolecular Sensors and Ion DetectionAdvanced Fluorescence Microscopy Techniques

Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes

Open access
Edgington, Laura E, Verdoes, Martijn, Bogyo, Matthew·2011·Current Opinion in Chemical Biology

Abstract

Proteases are enzymes that cleave peptide bonds in protein substrates. This process can be important for regulated turnover of a target protein but it can also produce protein fragments that then perform other functions. Because the last few decades of protease research have confirmed that proteolysis is an essential regulatory process in both normal physiology and in multiple disease-associated conditions, there has been an increasing interest in developing methods to image protease activity. Proteases are also considered to be one of the few 'druggable' classes of proteins and therefore a large number of small molecule based inhibitors of proteases have been reported. These compounds serve as a starting point for the design of probes that can be used to target active proteases for imaging applications. Currently, several classes of fluorescent probes have been developed to visualize protease activity in live cells and even whole organisms. The two primary classes of protease probes make use of either peptide/protein substrates or covalent inhibitors that produce a fluorescent signal when bound to an active protease target. This review outlines some of the most recent advances in the design of imaging probes for proteases. In particular, it highlights the strengths and weaknesses of both substrate-based and activity-based probes and their applications for imaging cysteine proteases that are important biomarkers for multiple human diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cbpa.2011.10.012

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ABPP was pioneered by Cravatt and Bogyo using active-site-directed chemical probes that covalently target catalytic residues of hydrolases, proteases, and kinases.

    “ABPP was pioneered by Cravatt and Bogyo using active-site-directed chemical probes that covalently target catalytic residues of various enzyme classes, including hydrolases, proteases and kinases173,174.”

    From Advances in covalent drug discovery (2022) · cites this paper as [174]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 50 · Cited by 169

Research works printed but not linked: 1

  1. [8]Maly DJ Huang L Ellman JA Combinatorial strategies for targeting protein families: application to the proteases Chembiochem 2002 3 1 16 37 17590950

Authors
Edgington, L. E., Verdoes, M., & Bogyo, M.
Affiliations
Stanford Medicine (US)
Corresponding author
Bogyo, Matthew
Venue
Current Opinion in Chemical Biology
Publisher
Elsevier BV
Published
2011-12
Volume
15
Issue
6
Pages
798-805
ISSN
1367-5931 (ISSN-L)
OpenAlex
W2151362130
Cited by
169
References
50
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 9 · 2020: 6 · 2019: 17 · 2018: 11 · 2017: 8 · 2016: 13 · 2015: 23 · 2014: 24 · 2013: 18 · 2012: 11
FWCI
1.24
Type
journal article
Language
en
Open access
Locations
  • Current Opinion in Chemical Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (T32CA009302)
  • National Institute of Allergy and Infectious Diseases (R01AI078947, R21AI088541)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB005011)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Advanced Fluorescence Microscopy Techniques
Keywords
activity-based probes, fluorescent probes, protease inhibitors, cysteine protease, live-cell imaging, proteolysis, disease biomarkers
MeSH terms
Animals, Fluorescent Dyes, Humans, Hydrolases, Endopeptidases, Protease Inhibitors, Proteins, Structure-Activity Relationship, Substrate Specificity, Molecular Probes, Mice, Small Molecule Libraries, Molecular Imaging, Cysteine Proteases, Proteolysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review